Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Treasury Shares: 2022-2024

Historic Treasury Shares for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Dec 2024 value amounting to $143,002.

  • NewAmsterdam Pharma Co N.V's Treasury Shares rose 19.08% to $724,908 in Q3 2025 from the same period last year, while for Sep 2025 it was $724,908, marking a year-over-year increase of 19.08%. This contributed to the annual value of $143,002 for FY2024, which is 76.51% down from last year.
  • According to the latest figures from FY2024, NewAmsterdam Pharma Co N.V's Treasury Shares is $143,002, which was down 76.51% from $608,779 recorded in FY2023.
  • NewAmsterdam Pharma Co N.V's Treasury Shares' 5-year high stood at $608,779 during FY2022, with a 5-year trough of $143,002 in FY2024.
  • Its 3-year average for Treasury Shares is $453,520, with a median of $608,779 in 2023.
  • Data for NewAmsterdam Pharma Co N.V's Treasury Shares shows a maximum YoY crashed of 76.51% (in 2024) over the last 5 years.
  • NewAmsterdam Pharma Co N.V's Treasury Shares (Yearly) stood at $608,779 in 2022, then remained steady at $608,779 in 2023, then plummeted by 76.51% to $143,002 in 2024.